Spots Global Cancer Trial Database for Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer
Official Title: A Phase I/II Clinical Trial of Immunotherapy With Humanized MN-14 IgG in Recurrent, Metastatic, Unresectable Colorectal and Breast Carcinomas
Study ID: NCT00041652
Interventions
Study Description
Brief Summary: The purpose of this trial is to determine the safety of hMN14 at different dose levels in the treatment of either colorectal or breast cancer.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hoag Cancer Center, Newport Beach, California, United States
Contact Details
Name: Terence Rugg, MD
Affiliation: Gilead Sciences
Role: STUDY_DIRECTOR
Name: Lauri Welles, MD
Affiliation: Gilead Sciences
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
